197 related articles for article (PubMed ID: 38105257)
1. Mimicking hypomethylation of FUS requires liquid-liquid phase separation to induce synaptic dysfunctions.
Kim SC; Mitchell SJ; Qamar S; Whitcomb DJ; Ruepp MD; St George-Hyslop P; Cho K
Acta Neuropathol Commun; 2023 Dec; 11(1):199. PubMed ID: 38105257
[TBL] [Abstract][Full Text] [Related]
2. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR
Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723
[TBL] [Abstract][Full Text] [Related]
3. FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation-π Interactions.
Qamar S; Wang G; Randle SJ; Ruggeri FS; Varela JA; Lin JQ; Phillips EC; Miyashita A; Williams D; Ströhl F; Meadows W; Ferry R; Dardov VJ; Tartaglia GG; Farrer LA; Kaminski Schierle GS; Kaminski CF; Holt CE; Fraser PE; Schmitt-Ulms G; Klenerman D; Knowles T; Vendruscolo M; St George-Hyslop P
Cell; 2018 Apr; 173(3):720-734.e15. PubMed ID: 29677515
[TBL] [Abstract][Full Text] [Related]
4. The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene.
Snowden JS; Hu Q; Rollinson S; Halliwell N; Robinson A; Davidson YS; Momeni P; Baborie A; Griffiths TD; Jaros E; Perry RH; Richardson A; Pickering-Brown SM; Neary D; Mann DM
Acta Neuropathol; 2011 Jul; 122(1):99-110. PubMed ID: 21424531
[TBL] [Abstract][Full Text] [Related]
5. RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration.
Hofmann JW; Seeley WW; Huang EJ
Annu Rev Pathol; 2019 Jan; 14():469-495. PubMed ID: 30355151
[TBL] [Abstract][Full Text] [Related]
6. Expanding the Phenotype of Frontotemporal Lobar Degeneration With FUS-Positive Pathology (FTLD-FUS).
Chornenka K; Hirsch-Reinshagen V; Perez-Rosendahl M; Feldman H; Segal-Gidan F; Vinters HV; Mackenzie IR
J Neuropathol Exp Neurol; 2020 Jul; 79(7):809-812. PubMed ID: 32483606
[TBL] [Abstract][Full Text] [Related]
7. Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS.
Suárez-Calvet M; Neumann M; Arzberger T; Abou-Ajram C; Funk E; Hartmann H; Edbauer D; Kremmer E; Göbl C; Resch M; Bourgeois B; Madl T; Reber S; Jutzi D; Ruepp MD; Mackenzie IR; Ansorge O; Dormann D; Haass C
Acta Neuropathol; 2016 Apr; 131(4):587-604. PubMed ID: 26895297
[TBL] [Abstract][Full Text] [Related]
8. Brain region-specific synaptic function of FUS underlies the FTLD-linked behavioural disinhibition.
Wang JY; Ma GM; Tang XQ; Shi QL; Yu MC; Lou MM; He KW; Wang WY
Brain; 2023 May; 146(5):2107-2119. PubMed ID: 36345573
[TBL] [Abstract][Full Text] [Related]
9. Inherited and Sporadic Amyotrophic Lateral Sclerosis and Fronto-Temporal Lobar Degenerations arising from Pathological Condensates of Phase Separating Proteins.
Fernandopulle M; Wang G; Nixon-Abell J; Qamar S; Balaji V; Morihara R; St George-Hyslop PH
Hum Mol Genet; 2019 Nov; 28(R2):R187-R196. PubMed ID: 31595953
[TBL] [Abstract][Full Text] [Related]
10. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.
Urwin H; Josephs KA; Rohrer JD; Mackenzie IR; Neumann M; Authier A; Seelaar H; Van Swieten JC; Brown JM; Johannsen P; Nielsen JE; Holm IE; ; Dickson DW; Rademakers R; Graff-Radford NR; Parisi JE; Petersen RC; Hatanpaa KJ; White CL; Weiner MF; Geser F; Van Deerlin VM; Trojanowski JQ; Miller BL; Seeley WW; van der Zee J; Kumar-Singh S; Engelborghs S; De Deyn PP; Van Broeckhoven C; Bigio EH; Deng HX; Halliday GM; Kril JJ; Munoz DG; Mann DM; Pickering-Brown SM; Doodeman V; Adamson G; Ghazi-Noori S; Fisher EM; Holton JL; Revesz T; Rossor MN; Collinge J; Mead S; Isaacs AM
Acta Neuropathol; 2010 Jul; 120(1):33-41. PubMed ID: 20490813
[TBL] [Abstract][Full Text] [Related]
11. Frontotemporal lobar degeneration: diversity of FTLD lesions.
Seilhean D; Bielle F; Plu I; Duyckaerts C
Rev Neurol (Paris); 2013 Oct; 169(10):786-92. PubMed ID: 24035575
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD).
Lourenco GF; Janitz M; Huang Y; Halliday GM
Neurobiol Dis; 2015 Oct; 82():445-454. PubMed ID: 26220395
[TBL] [Abstract][Full Text] [Related]
13. A postzygotic de novo NCDN mutation identified in a sporadic FTLD patient results in neurochondrin haploinsufficiency and altered FUS granule dynamics.
Nicolas G; Sévigny M; Lecoquierre F; Marguet F; Deschênes A; Del Pelaez MC; Feuillette S; Audebrand A; Lecourtois M; Rousseau S; Richard AC; Cassinari K; Deramecourt V; Duyckaerts C; Boland A; Deleuze JF; Meyer V; Clarimon Echavarria J; Gelpi E; Akiyama H; Hasegawa M; Kawakami I; Wong TH; Van Rooij JGJ; Van Swieten JC; Campion D; Dutchak PA; Wallon D; Lavoie-Cardinal F; Laquerrière A; Rovelet-Lecrux A; Sephton CF
Acta Neuropathol Commun; 2022 Feb; 10(1):20. PubMed ID: 35151370
[TBL] [Abstract][Full Text] [Related]
14. Nuclear carrier and RNA-binding proteins in frontotemporal lobar degeneration associated with fused in sarcoma (FUS) pathological changes.
Davidson YS; Robinson AC; Hu Q; Mishra M; Baborie A; Jaros E; Perry RH; Cairns NJ; Richardson A; Gerhard A; Neary D; Snowden JS; Bigio EH; Mann DM
Neuropathol Appl Neurobiol; 2013 Feb; 39(2):157-65. PubMed ID: 22497712
[TBL] [Abstract][Full Text] [Related]
15. Very early-onset behavioral variant frontotemporal dementia in a patient with a variant of uncertain significance of a
Aguzzoli CS; Battista P; Hadad R; Ferreira Felloni Borges Y; Schilling LP; Miller BL
Neurocase; 2022 Aug; 28(4):403-409. PubMed ID: 36228146
[TBL] [Abstract][Full Text] [Related]
16. FUS/TLS genetic variability in sporadic frontotemporal lobar degeneration.
Cantoni C; Fenoglio C; Cortini F; Venturelli E; Villa C; Clerici F; Marcone A; Benussi L; Ghidoni R; Gallone S; Scalabrini D; Franceschi M; Cappa S; Binetti G; Mariani C; Rainero I; Giordana MT; Bresolin N; Scarpini E; Galimberti D
J Alzheimers Dis; 2010; 19(4):1317-22. PubMed ID: 20061612
[TBL] [Abstract][Full Text] [Related]
17. Fused in sarcoma (FUS): an oncogene goes awry in neurodegeneration.
Dormann D; Haass C
Mol Cell Neurosci; 2013 Sep; 56():475-86. PubMed ID: 23557964
[TBL] [Abstract][Full Text] [Related]
18. Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition.
Pelaez MC; Desmeules A; Gelon PA; Glasson B; Marcadet L; Rodgers A; Phaneuf D; Pozzi S; Dutchak PA; Julien JP; Sephton CF
Acta Neuropathol Commun; 2023 Nov; 11(1):182. PubMed ID: 37974279
[TBL] [Abstract][Full Text] [Related]
19. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.
Ratti A; Buratti E
J Neurochem; 2016 Aug; 138 Suppl 1():95-111. PubMed ID: 27015757
[TBL] [Abstract][Full Text] [Related]
20. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.
Neumann M
Rev Neurol (Paris); 2013 Oct; 169(10):793-8. PubMed ID: 24011641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
